10-K Filing

GLUCOSE HEALTH, INC. CIK: 1420108 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001477932-15-001981`
Period End Date	20141231
Filing Date	20150330
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	bisu-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 61 Income Statement 38 Cash Flow Statement 42 Stockholders Equity 25

Balance Sheet 61 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, Par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, Par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Cash	`Cash`	$4.87K	USD	Point-in-time
Cash	`Cash`	$711.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1,000.00	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1,000.00	shares	Point-in-time
Inventory	`InventoryNet`	$24.88K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1,000.00	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$38.86K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1,000.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.59K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$43.73K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Intellectual assets, net of accumulated amortization of $0 and $0, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$300.00	USD	Point-in-time
Intellectual assets, net of accumulated amortization of $0 and $0, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	1.31M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	377,456.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	1.31M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	377,456.00	shares	Point-in-time
TOTAL ASSETS	`Assets`	$44.03K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$25.59K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$144.63K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$154.66K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$7.75K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$6.00K	USD	Point-in-time
Note payable, related party	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Note payable, related party	`DueToRelatedPartiesCurrent`	$1.67K	USD	Point-in-time
Convertible notes payable, related parties	`ConvertibleNotesPayableCurrent`	$23.93K	USD	Point-in-time
Convertible notes payable, related parties	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayable`	$71.04K	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayable`	$138.25K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$223.35K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$324.58K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$223.35K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$324.58K	USD	Point-in-time
Preferred stock, $ no par value, 1,000 shares authorized,1,000 and -0- shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $ no par value, 1,000 shares authorized,1,000 and -0- shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively	`PreferredStockValue`	$113.20K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized,1,309,825 and 377,456 shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively (1)	`CommonStockValue`	$1.31K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized,1,309,825 and 377,456 shares issued and outstanding as of December 31, 2014 and December 31, 2013, respectively (1)	`CommonStockValue`	$377.00	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$5.23M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$4.76M	USD	Point-in-time
Stock subscription	`CommonStockSharesSubscriptions`	$34.40K	USD	Point-in-time
Stock subscription	`CommonStockSharesSubscriptions`	$23.00K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-17.37K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	-	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.90M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.57M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-280.55K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$22.20K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-197.76K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$44.03K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$25.59K	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	$224.00	USD	Annual
REVENUE	`SalesRevenueGoodsNet`	$2.74K	USD	Annual
Cost of revenues	`CostOfRevenue`	$2.31K	USD	Annual
Cost of revenues	`CostOfRevenue`	$2.64K	USD	Annual
Inventory impairment	`ImpairmentChargeOnReclassifiedAssets`	$20.83K	USD	Annual
Inventory impairment	`ImpairmentChargeOnReclassifiedAssets`	-	USD	Annual
Total Cost of Revenues	`CostOfGoodsAndServicesSold`	$23.46K	USD	Annual
Total Cost of Revenues	`CostOfGoodsAndServicesSold`	$2.31K	USD	Annual
GROSS LOSS	`GrossProfit`	$-2.09K	USD	Annual
GROSS LOSS	`GrossProfit`	$-20.73K	USD	Annual
Professional fees/stock based compensation	`SalariesAndWages`	$1.03M	USD	Annual
Professional fees/stock based compensation	`SalariesAndWages`	$504.19K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$16.30K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$39.50K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	-	USD	Annual
Impairment	`ImpairmentOfInvestments`	$200.00K	USD	Annual
Impairment	`ImpairmentOfInvestments`	-	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.27M	USD	Annual
Total operating expenses	`OperatingExpenses`	$524.49K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-1.27M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-545.22K	USD	Annual
Interest income (expense)	`InterestExpense`	$168.86K	USD	Annual
Interest income (expense)	`InterestExpense`	$109.63K	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-14.56K	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-21.00K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-189.86K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-124.19K	USD	Annual
LOSS BEFORE IMCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.46M	USD	Annual
LOSS BEFORE IMCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-669.41K	USD	Annual
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	Annual
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	Annual
NET LOSS	`NetIncomeLoss`	$-669.41K	USD	Annual
NET LOSS	`NetIncomeLoss`	$-1.46M	USD	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	675,155.00	shares	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	297,225.00	shares	Annual
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	$-4.91	USD	Annual
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	$-0.99	USD	Annual

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-669.41K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Impairment expense	`AssetImpairmentCharges`	$200.00K	USD	Annual
Impairment expense	`AssetImpairmentCharges`	-	USD	Annual
Inventory write down	`InventoryWriteDown`	$14.40K	USD	Annual
Inventory write down	`InventoryWriteDown`	-	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$925.68K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$372.73K	USD	Annual
Amortization of note discount	`AmortizationOfNoteDiscount`	$-100.10K	USD	Annual
Amortization of note discount	`AmortizationOfNoteDiscount`	$-172.97K	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-14.56K	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-21.00K	USD	Annual
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$-10.48K	USD	Annual
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$24.88K	USD	Annual
(Increase) in prepaids	`IncreaseDecreaseInPrepaidExpense`	-	USD	Annual
(Increase) in prepaids	`IncreaseDecreaseInPrepaidExpense`	-	USD	Annual
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$21.79K	USD	Annual
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$32.39K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.33M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$534.06K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-135.35K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-131.99K	USD	Annual
Proceeds from notes and loans payable	`ProceedsFromNotesPayable`	$139.51K	USD	Annual
Proceeds from notes and loans payable	`ProceedsFromNotesPayable`	$134.22K	USD	Annual
Principal payments on notes and loans payable	`PrincipalPaymentsOnNotesAndLoansPayable`	$-2.60K	USD	Annual
Principal payments on notes and loans payable	`PrincipalPaymentsOnNotesAndLoansPayable`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$139.51K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$131.62K	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-365.00	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.16K	USD	Annual
CASH - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$711.00	USD	Point-in-time
CASH - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.08K	USD	Point-in-time
CASH - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$711.00	USD	Point-in-time
CASH - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$4.87K	USD	Point-in-time
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$131.76K	USD	Annual
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$54.79K	USD	Annual
Cancellation for 600,000 shares of common stock to settle liabilities	`CancellationFor600000SharesOfCommonStockToSettleLiabilities`	-	shares	Annual
Cancellation for 600,000 shares of common stock to settle liabilities	`CancellationFor600000SharesOfCommonStockToSettleLiabilities`	21,000.00	shares	Annual
Conversion of liability to common stock	`StockIssued1`	$6.38K	USD	Annual
Conversion of liability to common stock	`StockIssued1`	-	USD	Annual
Acquisition of intellectual property of Glucose Health Natural Blood Sugar Maintenance product for common shares	`AcquisitionOfIntellectualProperty`	$300.00	USD	Annual
Acquisition of intellectual property of Glucose Health Natural Blood Sugar Maintenance product for common shares	`AcquisitionOfIntellectualProperty`	-	USD	Annual

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$-280.55K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$22.20K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-197.76K	USD	Point-in-time
Common shares issued for services, Amount	`CommonSharesIssuedForServicesAmount`	$115.16K	USD	Annual
Common shares issued for services, Amount	`CommonSharesIssuedForServicesAmount`	$761.05K	USD	Annual
Common shares issued for settlement of notes payable, Amount	`CommonSharesIssuedForSettlementOfNotesPayableAmount`	$54.79K	USD	Annual
Common shares issued for settlement of notes payable, Amount	`CommonSharesIssuedForSettlementOfNotesPayableAmount`	$131.76K	USD	Annual
Common shares issued for settlement of accounts payable, Amount	`CommonSharesIssuedForSettlementOfAccountsPayableAmount`	$6.38K	USD	Annual
Stock to be issued	`StockToBeIssued`	$34.40K	USD	Annual
Stock to be issued	`StockToBeIssued`	$-11.40K	USD	Annual
Discounts on shares issued for notes payable Q312:	`DiscountsOnSharesIssuedForNotesPayable`	$172.97K	USD	Annual
Discounts on shares issued for notes payable Q312:	`DiscountsOnSharesIssuedForNotesPayable`	$116.94K	USD	Annual
Amortization of deferred compensation	`AmortizationOfDeferredCompensation`	$17.37K	USD	Annual
Amortization of deferred compensation	`AmortizationOfDeferredCompensation`	$132.63K	USD	Annual
Preferred shares issued for compensation under employment agreement, Amount	`PreferredSharesIssuedForCompensationUnderEmploymentAgreementAmount`	$113.20K	USD	Annual
Common shares issued for compensation under employment agreement, Amount	`CommonSharesIssuedForCompensationUnderEmploymentAgreementAmount`	$114.00K	USD	Annual
Common shares issued for liability for stock to be issued, Amount	`CommonSharesIssuedForLiabilityForStockToBeIssuedAmount`	$14.40K	USD	Annual
Common shares issued for Glucose Health Natural Blood Sugar Maintenance product acquisition, Amount	`CommonSharesIssuedForGlucoseHealthNaturalBloodSugarMaintenanceProductAcquisitionAmount`	$300.00	USD	Annual
Options issued for service	`OptionsIssuedForService`	$51.85K	USD	Annual
Factional shares issued, Amount	`FactionalSharesIssuedAmount`	-	USD	Annual
Net loss for the year	`NetIncomeLoss`	$-669.41K	USD	Annual
Net loss for the year	`NetIncomeLoss`	$-1.46M	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$-280.55K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$22.20K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-197.76K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.